Market Scenario:
During the last few years, there is a significant increase in
the demand for cardiovascular devices. According to the World Health
Organization (WHO), in 2015, over 17.7 million people died from cardiovascular
diseases, representing 31% of all global deaths. According to the findings from
the WHO, in 2015, 82% of the total deaths occurred were in the low- and
middle-income countries. Additionally, according to the Centers for Disease
Control and Prevention (2015), over 630,000 Americans die from heart disease
each year, which accounts for 1 in every 4 deaths. Additionally,
increasing geriatric population and increasing healthcare expenditure have
fuelled the growth of the market. However, the cardiovascular devices
manufacturers need to follow the rules stated by FDA and have to compliance
with policies and procedures related to the manufacturing of these devices.
Strict regulatory rules and high cost of the devices may slow the growth of the
market during the forecast period.
The cardiovascular application market is expected to grow at
a CAGR of 7.24% during the forecast period and is estimated to reach USD
36730.5 million by 2023.
Segments:
The global cardiovascular application market has been
segmented on the basis of devices and end users.
On the basis of the devices, the global cardiovascular
application market is segmented into the cardiac pacemaker, defibrillators,
monitors, and others. The cardiac monitors are further segmented into resting
ECG, ECG monitors, holter monitors, implantable loop recorder, and others. The
cardiac pacemaker are further segmented into implantable cardiac pacemaker, and
external cardiac pacemaker.
On the basis of the end users, the market is segmented into
cardiac care centers, ambulatory centers & home care, academic institutes,
and others.
Intended Audience:
·
Cardiovascular Products Manufacturers
·
Cardiovascular Products Providers
·
Medical Research Laboratories
·
Research and Development (R&D) Companies
·
Market Research and Consulting Service Providers
·
Potential Investors
Key
Findings:
The global cardiovascular application market is growing at a
growth rate of 7.24% during the forecast period 2017-2023. Increasing
prevalence of the cardiovascular diseases, increasing geriatric population, and
technological advances are some of the major factors responsible for market
growth
The market is categorized into number of different
cardiovascular devices. The category of cardiac monitors holds the major share
in the market.
General Electric Company, Koninklijke Philips N.V, Abbott,
and Medtronic are some of the prominent market players in the cardiovascular
application market
Regional
Analysis:
The Americas accounted for the major share of the market
owing to the presence of a huge population of patients suffering from
cardiovascular diseases, high healthcare expenditure, well-developed
technology, and the presence of the leading players. Furthermore, rising
government support for the development of the advanced devices and
well-developed healthcare sector has boosted the growth of the cardiovascular
application market in the Americas.
Asia Pacific is the fastest growing cardiovascular
application market. Increasing need for better devices, rapidly improving
technology, and the presence of huge patient pool is driving the growth of the
market in this region. The Middle East & Africa holds the least share of
the market owing to the presence of poor and slow developing countries,
especially, in the African region. The major driving factors for the growth of
the Middle East & African cardiovascular application market are increasing
aging population and increasing number of diabetic and cardiovascular patients.
Key players
in the global cardiovascular application
market:
Some of the major players in this market are Abbott (U.S.),
General Electric Company (U.S.), Medtronic (Ireland), Boston Scientific
Corporation (U.S.), KONINKLIJKE PHILIPS N.V. (The Netherlands), Terumo (Japan),
Stryker Corporation (U.S.), Edwards Lifesciences (U.S.), Allergan Inc. (U.S.),
Smith & Nephew plc (U.K), CR Bard Inc. (U.S.), Sonova Holdings
(Switzerland), and Dragerwerk AG & Co. KGa (Germany)
Get Your
Customized Report @https://www.marketresearchfuture.com/reports/type-2-diabetes-mellitus-treatment-market-5669
Table of
Content:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC
Continued…!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
No comments:
Post a Comment